Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03717831 · ClinicalTrials.gov registry record
Muscle Dysfunction in Critical Illness
A clinical trial, sponsored by University of Kentucky.
- Completed
- Registry status
- 66
- Enrollment target
NCT03717831: Completed study, sponsored by University of Kentucky.
NCT03717831 is a clinical trial that has completed, run by University of Kentucky. The registered enrollment target is 66 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03717831 has completed, sponsored by University of Kentucky.
- COMPLETED
- Registry status
- 66 participants
- Enrollment target
Study Summary
Patients surviving critical illness suffered significant skeletal muscle dysfunction and weakness that impacts their functionality and independence. The primary purpose of this project is to develop a classification system based on the health and function of the muscle at very early time points during critical illness. The investigators will determine if muscle ultrasound can predict functional recovery at six-months post hospital discharge. Researchers will assess muscle health and function from starting day one of admission to ICU and continue until six months of recovery. In addition to muscle ultrasound, the investigators will assess muscle strength and power, and perform muscle tissue analysis on a subset of individuals. These findings will be correlated to physical function and independence at six-month follow-up.
Primary Outcome
Gait speed measured with 4 meter (Short Performance Physical Battery)
Interventions
- OTHER Observational study of standard of care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2018-10-17 |
| Est. Completion | 2019-07-15 |
What the finished NCT03717831 record still lists
NCT03717831 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 66 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Observational study of standard of care is the first listed.
NCT03717831 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03717831 about?
NCT03717831 is a clinical study titled "Muscle Dysfunction in Critical Illness". Patients surviving critical illness suffered significant skeletal muscle dysfunction and weakness that impacts their functionality and independence. The primary purpose of this project is to develop a classification system based on the health and function of the muscle at very early time points duri...
What is the current status of trial NCT03717831?
This trial is currently completed. The enrollment target is 66 participants. The study started on 2018-10-17. Estimated completion is 2019-07-15.
What interventions are being tested in trial NCT03717831?
The interventions under investigation include: Observational study of standard of care (OTHER).
Who is sponsoring clinical trial NCT03717831?
This trial is sponsored by University of Kentucky, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI